Carvedilol phosphate hemihydrate - CAS# 610309-89-2 2515 The efficacy and adoption of

The efficacy and adoption of oral rehydration therapy would be enhanced by a drug that reduces fluid loss associated with these diseases and alleviates disease symptoms

InChiKey: NACOJBQGIGOFFX-FOFPIWDISA-N

including ERK1/2

PR and AR in binding assays

PubMed PMID: 17121910

Carvedilol phosphate hemihydrate - CAS# 610309-89-2 2515 The efficacy and adoption ofCarvedilol phosphate hemihydrate (BM 14190 phosphate hemihydrate) is a non selective 1 blocker. Carvedilol phosphate hemihydrate inhibits lipid peroxidation with an IC50 of 5 M. Carvedilol phosphate hemihydrate is a multiple action antihypertensive agent with potential use in angina and congestive heart failure. Carvedilol phosphate hemihydrate is an autophagy inducer that inhibits the NLRP3 inflammasome. Product information CAS Number: 610309 89 2